Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Melanie Gleason

Concepts (122)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
School Health Services
10
2024
218
1.260
Why?
Asthma
21
2024
1800
1.190
Why?
School Nursing
4
2024
34
0.560
Why?
Health Personnel
2
2017
754
0.380
Why?
Anti-Asthmatic Agents
6
2017
263
0.320
Why?
Respiratory Sounds
1
2022
102
0.170
Why?
Child
20
2024
22693
0.150
Why?
Schools
4
2022
436
0.140
Why?
Program Development
2
2018
371
0.140
Why?
Population
1
2018
30
0.140
Why?
Self Care
2
2016
396
0.120
Why?
Disease Management
2
2018
651
0.120
Why?
Competency-Based Education
1
2016
83
0.120
Why?
Urban Population
1
2018
497
0.110
Why?
Nurse's Role
1
2016
148
0.110
Why?
Prednisone
2
2015
229
0.110
Why?
Program Evaluation
1
2018
952
0.100
Why?
Evidence-Based Practice
1
2016
231
0.100
Why?
Colorado
6
2024
4595
0.100
Why?
Virus Diseases
1
2015
219
0.090
Why?
Adolescent
13
2024
22557
0.090
Why?
Child, Preschool
9
2022
11913
0.080
Why?
Healthcare Disparities
1
2018
733
0.080
Why?
Spirometry
3
2022
234
0.080
Why?
Practice Guidelines as Topic
2
2016
1591
0.080
Why?
Communication
1
2017
980
0.080
Why?
Nitric Oxide
1
2015
883
0.080
Why?
Health Promotion
1
2016
786
0.070
Why?
Humans
23
2024
146342
0.070
Why?
Immunoglobulin E
1
2010
315
0.070
Why?
Leukocytes, Mononuclear
1
2012
585
0.070
Why?
Parents
1
2017
1394
0.070
Why?
Adrenal Cortex Hormones
1
2012
486
0.070
Why?
Food Hypersensitivity
1
2010
165
0.070
Why?
Phosphodiesterase Inhibitors
1
2008
73
0.070
Why?
Aminopyridines
1
2008
128
0.060
Why?
Dermatitis, Atopic
1
2010
319
0.060
Why?
Benzamides
1
2008
226
0.060
Why?
Health Services Accessibility
2
2018
1107
0.060
Why?
Acetates
1
2006
78
0.060
Why?
Quinolines
1
2006
191
0.050
Why?
Pragmatic Clinical Trials as Topic
1
2024
135
0.050
Why?
Female
15
2024
79499
0.050
Why?
Drug Labeling
1
2003
37
0.050
Why?
Anti-Allergic Agents
1
2003
41
0.050
Why?
Vulnerable Populations
1
2024
178
0.050
Why?
Patient Dropouts
1
2003
65
0.050
Why?
United States Food and Drug Administration
1
2003
208
0.050
Why?
Male
14
2018
73396
0.040
Why?
Methacholine Chloride
1
2022
50
0.040
Why?
Bronchial Provocation Tests
1
2022
46
0.040
Why?
Forced Expiratory Volume
3
2015
451
0.040
Why?
Patient Compliance
1
2003
589
0.040
Why?
Connecticut
1
2018
25
0.040
Why?
Case Management
1
2018
66
0.030
Why?
Clinical Trials as Topic
1
2003
1064
0.030
Why?
Absenteeism
1
2018
51
0.030
Why?
Cyclopropanes
2
2008
83
0.030
Why?
Respiratory Function Tests
2
2012
543
0.030
Why?
Community Health Services
1
2018
229
0.030
Why?
Nursing Education Research
1
2016
43
0.030
Why?
Organizational Case Studies
1
2016
70
0.030
Why?
Airway Resistance
2
2006
38
0.030
Why?
Research Design
1
2022
1143
0.030
Why?
Plethysmography
2
2006
104
0.030
Why?
Exhalation
1
2015
28
0.030
Why?
Breath Tests
1
2015
77
0.030
Why?
Delivery of Health Care
1
2022
947
0.030
Why?
Patient Education as Topic
2
2014
770
0.030
Why?
Tomography, X-Ray Computed
1
2005
2786
0.030
Why?
Drug Resistance
2
2012
145
0.030
Why?
Focus Groups
1
2017
588
0.030
Why?
Family
1
2018
690
0.020
Why?
Polymerase Chain Reaction
1
2015
1031
0.020
Why?
Acute Disease
1
2015
1038
0.020
Why?
Dual Specificity Phosphatase 1
1
2012
24
0.020
Why?
Anti-Inflammatory Agents
1
2015
474
0.020
Why?
Interleukin-8
1
2012
268
0.020
Why?
Receptors, Glucocorticoid
1
2012
132
0.020
Why?
Immunoassay
1
2010
108
0.020
Why?
Double-Blind Method
2
2006
2070
0.020
Why?
Food
1
2010
149
0.020
Why?
Dexamethasone
1
2012
368
0.020
Why?
Students
1
2014
649
0.020
Why?
Clinical Competence
1
2016
1272
0.020
Why?
Glucocorticoids
1
1992
536
0.020
Why?
Half-Life
1
2008
157
0.020
Why?
Dose-Response Relationship, Drug
2
2008
2022
0.020
Why?
Allergens
1
2010
390
0.020
Why?
Area Under Curve
1
2008
335
0.020
Why?
Insurance, Health
1
2009
318
0.010
Why?
Lung Volume Measurements
1
2006
44
0.010
Why?
Chromatography, High Pressure Liquid
1
2008
588
0.010
Why?
Oscillometry
1
2006
35
0.010
Why?
Cross-Over Studies
1
2008
615
0.010
Why?
Sulfides
1
2006
92
0.010
Why?
United States
2
2018
16136
0.010
Why?
Tandem Mass Spectrometry
1
2008
576
0.010
Why?
Electrocardiography
1
2008
667
0.010
Why?
Airway Obstruction
1
2006
152
0.010
Why?
Cell Proliferation
1
2012
2502
0.010
Why?
Cells, Cultured
1
2012
4118
0.010
Why?
Nedocromil
1
2003
20
0.010
Why?
Cross-Sectional Studies
1
2015
5899
0.010
Why?
Budesonide
1
2003
49
0.010
Why?
T-Lymphocytes
1
2012
2012
0.010
Why?
Infant
2
2010
10114
0.010
Why?
Prognosis
1
2012
4351
0.010
Why?
Prospective Studies
1
2015
8123
0.010
Why?
Adult
2
2018
41087
0.010
Why?
Social Class
1
2003
260
0.010
Why?
Social Behavior
1
2003
279
0.010
Why?
Hypersensitivity
1
2003
253
0.010
Why?
Social Support
1
2003
646
0.010
Why?
Longitudinal Studies
1
2003
3017
0.010
Why?
Cognition
1
2003
1292
0.010
Why?
Inflammation
1
2005
2919
0.010
Why?
Young Adult
1
2010
14330
0.010
Why?
Theophylline
1
1992
41
0.010
Why?
Albuterol
1
1992
76
0.010
Why?
Retrospective Studies
1
2010
17438
0.010
Why?
Administration, Inhalation
1
1992
567
0.010
Why?
Gleason's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)